Ge Wang

Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Shukui Qin, Li Qiu, Shanzhi Gu et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 254 citations

Medicine, Oncology, Pharmacotherapy +10

miR‐224 promotion of cell migration and invasion by targeting Homeobox D 10 gene in human hepatocellular carcinoma

Qiong Li, Chenchen Ding, Chuan Chen et al. · Journal of Gastroenterology and Hepatology · 2013 · 126 citations

Medicine, Molecular Biology, Oncology +17

Identification and Characterization of Mitochondrial Targeting Sequence of Human Apurinic/Apyrimidinic Endonuclease 1

Mengxia Li, Zhaoyang Zhong, Jianwu Zhu et al. · Journal of Biological Chemistry · 2010 · 96 citations · Full text

Life Sciences, Genetics, Molecular Biology +9

Clinical study of recombinant adenovirus-p53 combined with fractionated stereotactic radiotherapy for hepatocellular carcinoma

Zhixiang Yang, Dong Wang, Ge Wang et al. · Journal of Cancer Research and Clinical Oncology · 2009 · 85 citations · Full text

Medicine, Oncology, Radiation Oncology +16

miR-363 promotes proliferation and chemo-resistance of human gastric cancer via targeting of FBW7 ubiquitin ligase expression

Pengfei Zhang, Lulu Sheng, Ge Wang et al. · Oncotarget · 2016 · 67 citations · Full text

Medicine, Molecular Biology, Oncology +17